Research is not a solo effort. ​ It takes teamwork. It takes belief. It takes collaboration. We know what it takes to beat blood cancer and so does @dr-ahlamq.bsky.social whose work is funded by @bloodcanceruk.bsky.social grant co-led by Lisa & @letimarchetti.bsky.social​ #BloodCancerAwarenessMonth​

🚨New work from the #NUCancer Paediatric Brain Tumour Group shows not all MYC/MYCN-amplified medulloblastomas are the same. 🔹 Some patients face near-incurable disease & need new therapies 🔹 Others can survive long-term with current treatment #ChildhoodCancer #Medulloblastoma

🧬 Engineered nanobodies binding and stabilizing cancer-mutant p16INK4a—without blocking its CDK6 interaction or cell-cycle arrest function, in press at Structure from Endicott @nucancer.bsky.social and @lauraitzhaki.bsky.social groups! 📖 www.cell.com/structure/fu...

Celebrating Excellence: NU Cancer Conference 2025 Prize winner spotlight 🏆 Congrats to Dr. Eleanor Hackney on winning a poster award! Eleanor shined a light on her research around the utility of multiple FIT testing in symptomatic colorectal cancer patients. 🧪 #CancerResearch

🎉 Huge congratulations to Prof. Linda Sharp, Dr. Laura Woods & Dr. Christina Dobson on receiving a £40,000 grant from @HDR_UK North for their 9-month project: “Epidemiology of Early Onset Colorectal Cancer in England” 👏 #ColorectalCancer #EarlyDiagnosis #PublicHealth

🚨 New publication Prof. Mike Waring & team have advanced micelle-promoted DNA-encoded library synthesis through surfactant optimisation. Published in @orgbiomolchem.rsc.org. 🔬 Read more: pubs.rsc.org/.../ArticleL... #CancerResearch #MedicinalChemistry #DrugDiscovery

Congratulations to two of our scientists, professors Ruth Plummer and Stephen O’Brien, who have been appointed as national cancer drug experts by @england.nhs.uk, leading in ensuring patients have the best possible access to new cancer treatments. #WeAreNCL

🏆 NU Cancer Conference 2025: Prize Winner Spotlight PhD student Eleanor Woodward won a Flash Talk Award for her work on characterising structural variants in tumour samples using long-read sequencing via @oxfordnanopore.bsky.social platforms. 🧬 #CancerResearch #PhDLife #WomenInSTEM

Congratulations to Abdullah Malik, who has recently been awarded a support grant from LIVErNorth, a support charity for #liver #cancer patients based in the North East.

🏆 #NUCancer Conference 2025: Prize Winner Spotlight Congratulations to Louisa Taylor, PhD, winner of a Flash Talk Award for her cutting-edge work on high-risk MYC-amplified #medulloblastoma. 🔬💡 #childhoodcancer #childhoodcancerawareness #pediatriccancer #cancerresearch

🎉Congratulations to Dr. Shelby Barnett on receiving the joint EPHAR-EACPT Young Investigator Award in translational Pharmacology. Great work Shelby! 👏 #NUcancer

We're delighted to share that @newcastleuni.bsky.social has officially approved renewal of the #NUCancerCentre for 2025-30. We look forward to continuing this important journey together over the next five years.

The NU Conference was a big success with a superb plenary from Ram DasGupta (CRUK Scotland). Prizes for talks - J Dishington (1st) and H Stewart; flash talks - E Woodward (1st), L Taylor (2nd); posters - E Hackney (1st), K Papa (2nd). Congrats and to all presenters for giving us a memorable day!

Dr Amy Collins is busy at her poster on modelling hepatocellular carcinoma at the 2025 EASL Liver Cancer Summit in Paris. Funding for her work from Cancer Research U.K.

An important new study on the genetics of liver cancer published today in Nature led by Prof Tom Bird of Edinburgh University with contributions from @damann1.bsky.social, @jleslie1.bsky.social and others of @nucancer.bsky.social.

It was a pleasure hosting @walkolab.bsky.social from the Bart's Centre for Squamous Cancer in our NUCoRE Cancer seminar series this week where he told us about his exciting research on transcriptional addiction.

Our talented PhD student Keara wins a regional prize for her work on developing a 96-well scale model of liver cancer tumour microenvironment. Congratulations Keara!

Today is World Cancer Day. At the NU Centre for Cancer we are dedicated to working towards more effective and gentler treatments for cancer patients.

4 NU Cancer PhD studentships have just been awarded! Projects include multi-omic analysis of childhood medulloblastoma, modelling prostate cancer, identifying mitochondrial targets, and functional investigation of TP53 mutations in Burkitt Lymphoma. sway.cloud.microsoft/lBcDTPEyC7TD...

A great opportunity for PhD study on an important cancer with supervision by one of our rising stars!

PhD post available: Are you interested in using contemporary ‘omics approaches to uncover clinically-relevant biology in medulloblastoma, the most common malignant brain tumour in children? Join our Childhood Brain Tumour Research team @nucancer.bsky.social See www.findaphd.com/phds/project...

We are very proud that our very own Professor Christine Harrison has been deservedly recognised with an OBE for her work on improving the scientific knowledge and care of childhood leukaemia. bloodcancer.org.uk/news/blood-c...

The genomic revolution has the potential to transform cancer care 🔬 NHS specialists play a crucial role in cancer care, and expanding the NHS workforce and integrating scientists into care teams is key to unlocking the potential of genomics 👇 cruk.ink/4goGNmD

The 65th British Association for Cancer Research Meeting in Edinburgh June 2025.

Congratulations to Kenneth Tan who passed his PhD viva on Tuesday 🎉 Kenneth has also recently taken up a position as a Technical Specialist in our structural biology group. Many thanks to his examiners, @nucancer.bsky.social's Luke Gaughan and @universityofleeds.bsky.social's Richard Bayliss!

We are one of just 7 UK cancer centres that are contributing to the CRUK Black Leaders in Cancer PhD Scholarship Programme. We have 10 exciting projects on offer to eligible candidates of Black heritage backgrounds. Read more about the scheme and what we have on offer www.ncl.ac.uk/cancer/train...

Did you know that scientists in our @cruk-si.bsky.social Drug Discovery Unit were the brains behind Rucaparib (PARP inhibitor) and Erdafitinib (FGFR inhibitor, both now clinically approved cancer medicines. Read more about our ground breaking drug discovery science here www.ncl.ac.uk/cancer/our-r...